Table 1.
Comparison of the Factors of the Non-Survivor Group versus the Survivor Group. (Data are Presented as Number (%) of Patients, Mean ± SD, or Median [IQR] Unless Indicated Otherwise)
| Factors | Total (n=164) | Non-Survivor (n=38) | Survivor (n=126) | P |
|---|---|---|---|---|
| Age (years) | 40.1±15.4 | 42.0±16.9 | 39.5±15.0 | 0.518 |
| Male (%) | 94 (57.3%) | 20 (52.7%) | 74 (58.7%) | 0.505 |
| Comorbidities | ||||
| Diabetes mellitus | 4 (2.4%) | 3 (7.9%) | 1 (0.8%) | 0.013 |
| Hypertension | 16 (9.8%) | 8 (2.1%) | 8 (6.3%) | 0.007 |
| Primary pathology | ||||
| Tumor | 72 (43.9%) | 12 (31.6%) | 60 (47.6%) | 0.081 |
| Trauma | 3 (1.8%) | 0 (0.0%) | 3 (2.4%) | 0.337 |
| Tuberculosis | 2 (1.2%) | 0 (0.0%) | 2 (1.2%) | 0.435 |
| Hepatitis B | 4 (2.4%) | 1 (2.6%) | 3 (2.4%) | 0.93 |
| GCS Score | 7.7±3.8 | 5.8±3.8 | 8.6±3.5 | 0.021 |
| Time from procedure to infection, days | 6 [2.5–13.5] | 13.5 [8–16.8] | 6 [2.0–12.0] | 0.084 |
| LOS, days | 26.5 [20.0–40.0] | 29.5 [19.3–42.0] | 26 [20.0–39.8] | 0.665 |
| Sepsis | 31 (18.9%) | 17 (44.7%) | 14 (11.1%) | P<0.001 |
| ICU admission | 61 (37.2%) | 27 (71.1%) | 34 (27%) | P<0.001 |
| Producing ESBLs | 62 (37.8%) | 20 (52.6%) | 42 (33.3%) | 0.032 |
| Surgical wound classification | ||||
| Clean | 68 (41.5%) | 17 (44.7%) | 51 (40.5%) | 0.640 |
| Clean-contaminated | 96 (58.5%) | 21 (55.3%) | 75 (59.5%) | 0.640 |
| EVD | 67 (40.9%) | 19 (50.0%) | 48 (38.1%) | 0.191 |
| LD | 92 (56.1%) | 23 (60.5%) | 69 (42.1%) | 0.530 |
| Ventilator | 42 (25.6%) | 21 (55.3%) | 21(16.7%) | P<0.001 |
| CSF leakage | 36 (22.0%) | 8 (21.1%) | 28 (22.2%) | 0.879 |
| Craniotomy | 89 (54.3%) | 25 (65.8%) | 64 (50.8%) | 0.104 |
Abbreviations: GCS, Glasgow Coma Scale; LOS, length of hospital stay; ICU, intensive care unit; ESBLs, extended-spectrum beta-lactamase; EVD, extra ventricular drainage; LD, lumbar drainage; CSF, cerebrospinal fluid.